Overview

Assessment of Postoperative Pain After Using Two Formulations of Calcium Hydroxide Intracanal Medication .

Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
Calcium hydroxide is advocated as an intracanal medication for various purposes, including prevention of post-treatment symptoms. Calcium hydroxide has a pain-controlling effect at different times when compared to non-intracanal medication . Aim: The aim of the study to compare between postoperative pain after using two formulations of calcium hydroxide intracanal medication with and without iodoform .
Phase:
Phase 4
Details
Lead Sponsor:
Suez Canal University
Treatments:
Calcium